ESR1 and breast carcinoma: Similarly, a multicenter study conducted in the Chinese population found that the association between breast cancer and the rs2267437 polymorphism was not statistically significant, but it was reported that this polymorphism increased the risk of breast cancer in estrogen receptor-negative/progesterone receptor-negative individuals [30].